Colgate-Palmolive (NYSE:CL – Get Free Report) is expected to release its Q3 2025 results before the market opens on Friday, October 31st. Analysts expect the company to announce earnings of $0.91 per share and revenue of $5.1707 billion for the quarter. Investors may visit the the company’s upcoming Q3 2025 earningresults page for the latest details on the call scheduled for Friday, October 31, 2025 at 8:30 AM ET.
Colgate-Palmolive (NYSE:CL – Get Free Report) last announced its quarterly earnings data on Friday, August 1st. The company reported $0.92 EPS for the quarter, topping the consensus estimate of $0.89 by $0.03. The business had revenue of $5.11 billion for the quarter, compared to analyst estimates of $5.03 billion. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The company’s revenue for the quarter was up 1.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.91 earnings per share. On average, analysts expect Colgate-Palmolive to post $4 EPS for the current fiscal year and $4 EPS for the next fiscal year.
Colgate-Palmolive Stock Performance
Shares of CL stock opened at $77.10 on Wednesday. The firm has a market cap of $62.31 billion, a price-to-earnings ratio of 21.66, a P/E/G ratio of 4.57 and a beta of 0.34. The company has a debt-to-equity ratio of 6.79, a quick ratio of 0.57 and a current ratio of 0.89. Colgate-Palmolive has a 52 week low of $76.68 and a 52 week high of $100.18. The firm’s 50-day simple moving average is $81.03 and its two-hundred day simple moving average is $86.71.
Colgate-Palmolive Dividend Announcement
Wall Street Analyst Weigh In
Several analysts have commented on CL shares. JPMorgan Chase & Co. lowered their price objective on shares of Colgate-Palmolive from $95.00 to $88.00 and set an “overweight” rating on the stock in a research report on Friday, October 10th. Wells Fargo & Company reduced their price objective on shares of Colgate-Palmolive from $83.00 to $80.00 and set an “underweight” rating for the company in a research note on Thursday, September 25th. Morgan Stanley reduced their price objective on shares of Colgate-Palmolive from $104.00 to $96.00 and set an “overweight” rating for the company in a research note on Monday, August 4th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Colgate-Palmolive in a research note on Wednesday, October 8th. Finally, Bank of America reduced their price objective on shares of Colgate-Palmolive from $98.00 to $88.00 and set a “buy” rating for the company in a research note on Wednesday, October 8th. Eight analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $91.50.
View Our Latest Stock Analysis on CL
Institutional Investors Weigh In On Colgate-Palmolive
A number of hedge funds have recently made changes to their positions in the business. Main Street Financial Solutions LLC raised its holdings in Colgate-Palmolive by 3.7% in the second quarter. Main Street Financial Solutions LLC now owns 4,233 shares of the company’s stock valued at $385,000 after acquiring an additional 151 shares in the last quarter. Evergreen Capital Management LLC raised its holdings in Colgate-Palmolive by 3.9% in the second quarter. Evergreen Capital Management LLC now owns 4,569 shares of the company’s stock valued at $415,000 after acquiring an additional 171 shares in the last quarter. Keel Point LLC raised its holdings in Colgate-Palmolive by 4.4% in the second quarter. Keel Point LLC now owns 4,616 shares of the company’s stock valued at $420,000 after acquiring an additional 193 shares in the last quarter. Diversify Wealth Management LLC raised its holdings in Colgate-Palmolive by 3.3% in the second quarter. Diversify Wealth Management LLC now owns 7,774 shares of the company’s stock valued at $661,000 after acquiring an additional 249 shares in the last quarter. Finally, Brighton Jones LLC raised its holdings in Colgate-Palmolive by 4.4% in the fourth quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock valued at $962,000 after acquiring an additional 450 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors.
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Articles
- Five stocks we like better than Colgate-Palmolive
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- The Drone Arms Race: From Battlefield to Balance Sheet
- Most Volatile Stocks, What Investors Need to Know
- Why Wall Street Is Backing These 3 Comeback Stocks
- ESG Stocks, What Investors Should Know
- Intel’s Breakout Quarter: More Than a Beat, It’s a Declaration
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.
